AR067439A1 - Virus quimericos antigenicos de virus de encefalitis de st. louis/virus dengue tipo 4 - Google Patents
Virus quimericos antigenicos de virus de encefalitis de st. louis/virus dengue tipo 4Info
- Publication number
- AR067439A1 AR067439A1 ARP080102567A ARP080102567A AR067439A1 AR 067439 A1 AR067439 A1 AR 067439A1 AR P080102567 A ARP080102567 A AR P080102567A AR P080102567 A ARP080102567 A AR P080102567A AR 067439 A1 AR067439 A1 AR 067439A1
- Authority
- AR
- Argentina
- Prior art keywords
- louis
- viruses
- virus
- dengue type
- virus dengue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24141—Use of virus, viral particle or viral elements as a vector
- C12N2770/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Virus quiméricos antigénicos atenuados de virus de encefalitis de St. Louis/virus dengue tipo 4, los cuales se pueden usar para preparar composiciones inmunogénicas, vacunas y reactivos de diagnostico. Se proveen métodos para preparar y usar los anteriores. Reivindicacion 1: Un ácido nucleico que comprende una primera secuencia de nucleotidos que codifica al menos una proteína estructural de un virus SLE y una segunda secuencia de nucleotidos que codifica al menos una proteína no estructural de un virus dengue.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93473007P | 2007-06-14 | 2007-06-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR067439A1 true AR067439A1 (es) | 2009-10-14 |
Family
ID=39744908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080102567A AR067439A1 (es) | 2007-06-14 | 2008-06-17 | Virus quimericos antigenicos de virus de encefalitis de st. louis/virus dengue tipo 4 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20100316670A1 (es) |
AR (1) | AR067439A1 (es) |
WO (1) | WO2008157136A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2435572B1 (en) | 2009-05-28 | 2017-08-16 | The United States of America, as Represented by The Secretary, Department of Health and Human Services | Antigenic chimeric tick-borne encephalitis virus (tbev)/dengue virus type 4 (den4) recombinant viruses |
SG176299A1 (en) | 2009-06-01 | 2012-01-30 | Inviragen Inc | Compositions and methods for administration of vaccines against dengue virus |
CA2770888C (en) | 2009-08-31 | 2020-04-14 | Gen-Probe Incorporated | Dengue virus assay |
TW201428101A (zh) * | 2012-11-08 | 2014-07-16 | Inviragen Inc | 登革熱病毒血清型4型之建構物的組成物、方法及用途 |
CA2933472A1 (en) | 2012-12-14 | 2014-06-19 | Takeda Vaccines, Inc. | Compositions, methods of administration and uses for trivalent dengue virus formulations |
JP2019511221A (ja) | 2016-03-11 | 2019-04-25 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 弱毒化された生ジカウイルスワクチン |
WO2018129160A1 (en) | 2017-01-06 | 2018-07-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Live attenuated flavivirus vaccines and methods of using and making same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6962708B1 (en) * | 1997-02-28 | 2005-11-08 | Acambis, Inc. | Chimeric flavivirus vaccines |
EP2290109B1 (en) * | 2001-05-22 | 2014-08-13 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
EP2339011B1 (en) * | 2002-01-10 | 2015-04-15 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | West Nile virus and Dengue 4 virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
-
2008
- 2008-06-10 WO PCT/US2008/066445 patent/WO2008157136A1/en active Application Filing
- 2008-06-10 US US12/664,293 patent/US20100316670A1/en not_active Abandoned
- 2008-06-17 AR ARP080102567A patent/AR067439A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008157136A1 (en) | 2008-12-24 |
US20100316670A1 (en) | 2010-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR067439A1 (es) | Virus quimericos antigenicos de virus de encefalitis de st. louis/virus dengue tipo 4 | |
ECSP088599A (es) | Virus quiméricos que presentan proteínas de superficie no nativas y usos de los mismos | |
AR071220A1 (es) | Astrovirus aviario depositado bajo el nuero cncm i-3895 | |
EA201201025A1 (ru) | Молекулы нуклеиновых кислот гриппа и вакцины, изготовленные из них | |
EA201591888A1 (ru) | Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов | |
BRPI0908489A2 (pt) | uso de compostos químicos e método para desenhar compostos químicos que atenuam ou inibem a infecção pelo vírus da dengue | |
BRPI0913012A2 (pt) | vírus do nilo ocidental/da dengue quiméricos | |
BR112014010823A2 (pt) | anticorpos gp41 neutralizantes e seus usos | |
WO2008039267A3 (en) | Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions | |
ECSP088591A (es) | Anticuerpos anti-il-23 humanos, composiciones, metodos y usos | |
MX2013010620A (es) | Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo. | |
JP2015524421A5 (es) | ||
ES2421543T3 (es) | Método para la preparación de virus y proteínas del PRRS, y kits de pruebas de diagnóstico para su detección | |
CL2011001343A1 (es) | Pestivirus quimerico que comprende un virus de la diarrea viral bovina (bvdv) que expresa proteina erns de antilope; celula huesped que lo comprende; acido nucleico que lo codifica; composicion inmunogenica que comprende el pestivirus; vacuna marcadora que comprende el bvdv quimerico. | |
EA201001045A1 (ru) | Модифицированный вирус гриппа | |
WO2012065105A3 (en) | Chimeric flavivirus vaccines | |
AR047581A1 (es) | Vacunas de calicivirus felino | |
AR059005A1 (es) | Virus quimericos del dengue | |
CO6541529A2 (es) | Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quimericos | |
AR057225A1 (es) | Vacunas marcadas contra el virus de la diarrea virica bovina | |
CO6670515A2 (es) | Vectores de parapoxvirus | |
AR082281A1 (es) | Vectores de parapoxvirus | |
GB2429711A (en) | Heart and skeletal muscle inflammation (HSMI) virus | |
BRPI0914060A2 (pt) | formulação para o tratamento de células que expressem proteínas do hcv e de mamíferos portadores de hepatite c, método para o tratamento de células infectadas pela cepa pj6/jfh1 do hcv genótipo 2a e uso de uma formulação | |
AR085800A1 (es) | Vacuna de rinitis equina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |